Pacini, Alessandra <br/><br/>
The α9α10 nicotinic receptor antagonist α-conotoxin RgIA prevents neuropathic pain induced by oxaliplatin treatment.  [electronic resource] 

 -  Experimental neurology  08 2016 
 - 37-48 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1090-2430 
<br/><br/><label>Standard No.: </label>10.1016/j.expneurol.2016.04.022  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antineoplastic Agents--toxicity<br/>Brain--drug effects<br/>Calcium-Binding Proteins--metabolism<br/>Conotoxins--therapeutic use<br/>Disease Models, Animal<br/>Dose-Response Relationship, Drug<br/>Ganglia, Spinal--pathology<br/>Glial Fibrillary Acidic Protein--metabolism<br/>Hyperalgesia--drug therapy<br/>Male<br/>Microfilament Proteins--metabolism<br/>Neuralgia--chemically induced<br/>Neuroglia--drug effects<br/>Nicotinic Antagonists--therapeutic use<br/>Organoplatinum Compounds--toxicity<br/>Oxaliplatin<br/>Pain Measurement<br/>Pain Threshold--drug effects<br/>Rats<br/>Rats, Sprague-Dawley<br/>Reaction Time--drug effects<br/>Spinal Cord--metabolism<br/>Time Factors